Fulcrum Therapeutics (FULC) Revenue (2020 - 2024)
Fulcrum Therapeutics (FULC) reported Revenue of $80.0 million for Q2 2024, up 8990.91% year-over-year from $880000.0 in Q3 2023, and up 9084.85% quarter-over-quarter from $871000.0 in Q4 2023.
Fulcrum Therapeutics (FULC) Revenue (2020 - 2024) Analysis & Trends
Fulcrum Therapeutics (FULC) has 5 years of Revenue data on file, last reported at $80.0 million in Q2 2024.
- Revenue for Q2 2024 came in at $80.0 million, up 8990.91% year-over-year; the trailing twelve-month figure through Jun 2025 was $80.0 million (down 2.0% YoY), and the FY2024 annual result was $80.0 million, up 2752.05% from the prior year.
- Revenue rose to $80.0 million in Q2 2024 per FULC's latest filing, from $871000.0 in the prior quarter.
- Over five years, Revenue peaked at $80.0 million in Q2 2024 and troughed at $295000.0 in Q1 2023.
- A 5-year average of $6.9 million and a median of $1.9 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue sank 88.62% in 2023, then soared 8990.91% in 2024.
- A 5-year view of Revenue shows it stood at $4.2 million in 2020, then increased by 19.72% to $5.1 million in 2021, then tumbled by 86.46% to $685000.0 in 2022, then grew by 27.15% to $871000.0 in 2023, then soared by 9084.85% to $80.0 million in 2024.
- Business Quant data shows FULC's Revenue at $80.0 million in Q2 2024, $871000.0 in Q4 2023, and $759000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Fulcrum Therapeutics | 267.51 Mn | 267.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 80.00 Mn |
| Dec 31, 2023 | 871,000.00 |
| Sep 30, 2023 | 759,000.00 |
| Jun 30, 2023 | 880,000.00 |
| Mar 31, 2023 | 295,000.00 |
| Dec 31, 2022 | 685,000.00 |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 2.59 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 4.94 Mn |
| Jun 30, 2021 | 4.38 Mn |
| Mar 31, 2021 | 4.79 Mn |
| Dec 31, 2020 | 4.23 Mn |
| Sep 30, 2020 | 1.85 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Mar 31, 2020 | 750,000.00 |